Literature DB >> 21271578

Synchronous second primary tumors in 2,016 head and neck cancer patients: role of symptom-directed panendoscopy.

Erlend Rennemo1, Ulf Zätterström, Morten Boysen.   

Abstract

OBJECTIVES/HYPOTHESIS: Second primary tumors (SPTs) are prevalent in head and neck cancer patients. Synchronous SPTs occur within the first 6 months after diagnosis of a first primary tumor. Work-up of first primary head and neck cancers may include panendoscopy if SPTs are suspected. It is unclear whether this strategy has significant impact on treatment results. STUDY
DESIGN: Prospectively recorded data on head and neck cancer patients treated at an academic tertiary referral center.
METHODS: The distribution of SPTs was retrieved from a database of 2,016 patients with head and neck cancer. Initial work-up included panendoscopy when an SPT was clinically suspected.
RESULTS: Of 2,016 patients, 49 (2.4%) had synchronous SPTs. Of these, there were 26 diagnosed simultaneously with the first primary tumor, of which 18 (69%) were located in areas covered by panendoscopy. The remaining 23 were nonsimultaneous synchronous SPTs; 10 of them were located at sites accessible by panendoscopy, of which 6 were in the bronchial tree. Median survival after simultaneous SPTs was 9 months versus 3 months after nonsimultaneous synchronous SPTs (P = not significant). The highest frequency of synchronous SPTs was seen with first primary tumors of the hard palate, the dorsum of the tongue, and of the mandibular gingiva.
CONCLUSIONS: Symptom-directed panendoscopy at initial work-up was successful at finding SPTs of the upper aerodigestive tract, but not SPTs located in the lower airways. Synchronous SPTs missed at initial work-up did not have significantly worse prognosis than simultaneous SPTs.
Copyright © 2010 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21271578     DOI: 10.1002/lary.21385

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Localized synchronous squamous cell carcinomas of the esophagus and hypopharynx treated with definitive concurrent chemoradiotherapy with a unified radiotherapy plan.

Authors:  J B Wallach; M M Rosenstein; S Kalnicki
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

2.  Random synchronous malignancy in male breast: a case report.

Authors:  Manjit Sarma; Chaitanya Borde; Padma Subramanyam; Palaniswamy Shanmuga Sundaram
Journal:  J Breast Cancer       Date:  2013-12-31       Impact factor: 3.588

3.  Multiple primary malignancies: analysis of 23 patients with at least three tumors.

Authors:  Ahmed Salem; Ramiz Abu-Hijlih; Fadwa Abdelrahman; Rim Turfa; Rula Amarin; Naim Farah; Maher Sughayer; Abdelatief Almousa; Jamal Khader
Journal:  J Gastrointest Cancer       Date:  2012-09

4.  A Synchronous undifferentiated nasopharyngeal carcinoma and infiltrating ductal carcinoma of the breast successfully treated with induction chemotherapy followed by local control of both tumours: a case report.

Authors:  Mohamed Mesmoudi; Tarik Mahfoud; Nabil Ismaili; Khadija Rami; Meryem Kamouni; Laila Jroundi; Hassan Errihani
Journal:  BMC Ear Nose Throat Disord       Date:  2011-06-09

Review 5.  Causes of death of patients with laryngeal cancer.

Authors:  Alfio Ferlito; Missak Haigentz; Patrick J Bradley; Carlos Suárez; Primož Strojan; Gregory T Wolf; Kerry D Olsen; William M Mendenhall; Vanni Mondin; Juan P Rodrigo; Carsten C Boedeker; Marc Hamoir; Dana M Hartl; Jennifer L Hunt; Kenneth O Devaney; Lester D R Thompson; Alessandra Rinaldo; Robert P Takes
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-17       Impact factor: 2.503

6.  Helical tomotherapy with simultaneous integrated boost dose painting for the treatment of synchronous primary cancers involving the head and neck.

Authors:  A M Chen; M E Daly; J Cui; H O Wooten; D G Farwell; J A Purdy
Journal:  Br J Radiol       Date:  2014-06-02       Impact factor: 3.039

7.  Risk factors for second primary neoplasia of esophagus in newly diagnosed head and neck cancer patients: a case-control study.

Authors:  Chen-Shuan Chung; Li-Jen Liao; Wu-Chia Lo; Yueh-Hung Chou; Yi-Chen Chang; Yu-Chin Lin; Wei-Fan Hsu; Pei-Wei Shueng; Tzong-Hsi Lee
Journal:  BMC Gastroenterol       Date:  2013-10-25       Impact factor: 3.067

8.  Complete remission of an early-stage laryngeal cancer under combined pembrolizumab and chemotherapy treatment of a synchronous lung adenocarcinoma.

Authors:  Maximilian Linxweiler; Jan Philipp Kühn; Christian Neubert; Fadi Khreish; Benedikt Balensiefer; Mathias Wagner; Bernhard Schick
Journal:  J Otolaryngol Head Neck Surg       Date:  2022-05-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.